Galecto Inc (GLTO)
0.6248
+0.01
(+1.18%)
USD |
NASDAQ |
May 23, 12:21
Galecto EPS Diluted (Quarterly): -0.20 for March 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.20 |
| December 31, 2023 | -0.23 |
| September 30, 2023 | -0.30 |
| June 30, 2023 | -0.41 |
| March 31, 2023 | -0.51 |
| December 31, 2022 | -0.55 |
| September 30, 2022 | -0.54 |
| June 30, 2022 | -0.67 |
| March 31, 2022 | -0.67 |
| December 31, 2021 | -0.53 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.50 |
| June 30, 2021 | -0.49 |
| March 31, 2021 | -0.53 |
| December 31, 2020 | -0.1555 |
| September 30, 2020 | -0.5843 |
| June 30, 2020 | -0.465 |
| March 31, 2020 | -0.4446 |
| December 31, 2019 | -2.024 |
| September 30, 2019 | -0.4314 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-2.024
Minimum
Dec 2019
-0.1555
Maximum
Dec 2020
-0.5386
Average
-0.50
Median
Sep 2021
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.8273 |
| Genmab A/S | 0.2939 |
| Ascendis Pharma A/S | -2.498 |
| Evaxion Biotech AS | -1.50 |
| IO Biotech Inc | -0.30 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.477M |
| Total Expenses (Quarterly) | 5.741M |
| Enterprise Value | -10.43M |
| Earnings Yield | -182.5% |